News

Date:
Over the past decades, demand for natural resources has accelerated to the extent that it is now widely considered a serious threat to the proper functioning of economies and societies owing to associated environmental problems such as climate change, biodiversity loss, desertification, and…
Date:
Business Wire: September 14, 2017 – BOSTON, MA, U.S.A., and PFÄFFIKON, Switzerland – Intarcia Therapeutics, Inc., and Numab Therapeutics AG today announced the achievement of a key milestone in their ongoing development partnership—the selection of a multispecific antibody construct targeting…
Date:
Business Wire: September 14, 2017 – NEW YORK, NY, and SAN DIEGO, CA, U.S.A. – Bristol-Myers Squibb Company (NYSE: BMY) and Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced a global collaboration and license agreement to develop subcutaneously administered Bristol-Myers Squibb immuno-…
Authors:
Date:
Business Wire: September 14, 2017 – CAMBRIDGE, MA, U.S.A. – Seqirus announced today that the U.S. Food and Drug Administration (FDA) has approved Afluria Quadrivalent (influenza vaccine) for use in people five years of age and older, extending the company’s broad portfolio of influenza vaccine…
Date:
BOCA RATON, FL, U.S.A. – TherapeuticsMD, Inc. (NYSE American: TXMD), an innovative women’s healthcare company, today announced the submission of the additional endometrial safety information that was requested by the Food and Drug Administration (FDA) in its recent General Advice Letter to the…
Date:
Business Wire: September 13, 2017 – LOS ANGELES, CA, U.S.A. – Biosciences, Inc., a bio-targeted nanomedicines company developing a novel nanoparticle drug delivery platform, with a proprietary oncology pipeline, announced that the U.S. Patent and Trademark Office has issued U.S. patent no. 9,757,…